Related Experiment Video
Updated: May 14, 2026

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models
Published on: June 30, 2023
Changes of mitochondria in atherosclerosis: possible determinant in the pathogenesis of the disease
Igor A Sobenin1, Margarita A Sazonova, Anton Y Postnov
1Russian Cardiology Research and Production Complex, 121552 Moscow, Russia.
Abstract:
Electron-microscopic analysis of atherosclerotic lesions demonstrated a high variability in the ultrastructural appearance of mitochondria in human aortic atherosclerotic lesions compared with the appearance of mitochondria in the normal parts of the aortic intima. This prompted us to suggest that the structural variations in the appearance of mitochondria might reflect the existence of somatic mutations in the human mitochondrial genome which could be a determinant of atherosclerosis. To test this hypothesis, we have compared the levels of heteroplasmy for several mitochondrial mutations previously proposed to be associated with different types of atherosclerotic lesions. The homogenates of unaffected aortic intimae and lipofibrous plaques of 12 male aortas were compared to reveal the average level of heteroplasmy for A1555G, C3256T, T3336T, G12315A, G14459A, and G15059A mutations of human mitochondrial genome. It has been shown at least four mutations of mitochondrial genome, namely, A1555G in MT-RNR1 gene, C3256T in MT-TL1 gene, G12315A in MT-TL2 gene, and G15059A in MT-CYB gene have significantly higher prevalence and mean value in lipofibrous plaques as compared to non-atherosclerotic intima, and therefore are associated with atherosclerosis. Somatic mutations in the human mitochondrial genome might play a role in the development of atherosclerosis. The mitochondrial mutations observed in our study should encourage further exploration of the concept that mitochondrial DNA heteroplasmy might be used as a biomarker of atherogenesis.
Insights
Somatic mitochondrial DNA mutations are linked to atherosclerosis. Four specific mutations showed higher prevalence in atherosclerotic plaques, suggesting their role in the disease and potential as biomarkers.
Area of Science:
- Cardiovascular Biology
- Genetics
- Mitochondrial Medicine
Background:
- Mitochondrial ultrastructure varies in human aortic atherosclerotic lesions.
- This variability suggests somatic mutations in the mitochondrial genome may influence atherosclerosis.
Purpose of the Study:
- To investigate the association between specific mitochondrial DNA mutations and atherosclerosis.
- To compare heteroplasmy levels of known mitochondrial mutations in atherosclerotic plaques versus normal aortic intima.
Main Methods:
- Analyzed aortic intima and lipofibrous plaque homogenates from 12 male aortas.
- Quantified heteroplasmy levels for mitochondrial mutations A1555G, C3256T, T3336T, G12315A, G14459A, and G15059A.
Main Results:
- Four mitochondrial mutations (A1555G, C3256T, G12315A, G15059A) were significantly more prevalent in lipofibrous plaques.
- These mutations showed higher mean heteroplasmy values in atherosclerotic lesions compared to non-atherosclerotic intima.
Conclusions:
- Somatic mutations in the mitochondrial genome are associated with atherosclerosis.
- Mitochondrial DNA heteroplasmy may serve as a biomarker for atherogenesis, warranting further research.
More Related Videos
Related Concept Videos
Atherosclerosis I: Introduction
Mitochondria
Mitochondrial Membranes
Coronary Artery Disease II: Pathophysiology
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Coronary Artery Disease I: Introduction

